FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new compounds of general formula I [X]n-Y-ZR1R2, wherein the radicals are specified in the description, effective as heparan sulphate-binding protein inhibitors. The invention also refers to a pharmaceutical or veterinary composition having heparan sulphate-binding protein inhibitory activity for preventing or treating a disorder in a mammal, and to the use of these compounds and compositions for antiangiogenic, antimetastatic, anti-inflammatory, antimicrobial, anticoagulant and/or antithrombotic therapy in a mammal.
EFFECT: preparing the new compounds of general formula I [X]n-Y-ZR1R2, wherein the radicals are specified in the description, effective as the heparan sulphate binding protein inhibitors.
10 cl, 31 ex, 11 tbl, 40 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| 3-DESOXYOLIGOSACCHARIDE DERIVATIVES, METHOD OF PREPARING THEREOF (VARIANTS), INTERMEDIATE COMPOUNDS, AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2133752C1 |
| NOVEL PENTASACCHARIDES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 1999 |
|
RU2193040C2 |
| SYNTHETIC POLYSACCHARIDES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 1997 |
|
RU2167163C2 |
| SYNTHETIC POLYSACCHARIDES, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 1999 |
|
RU2211224C2 |
| N-SULPHATED OLIGOSACCHARIDES ACTIVATING FGF RECEPTORS, PRODUCING AND USING THEM IN THERAPY | 2010 |
|
RU2559629C2 |
| GLUCOSE-RESPONSIVE INSULIN CONJUGATES | 2014 |
|
RU2676307C2 |
| DERIVATIVES OF OLIGOSACCHARIDES | 2004 |
|
RU2290408C2 |
| METHOD OF ISOLATING TRIOSIDE OF /(25R)-FUROST-5-EN-3BETA-22ALPHA,26 TRIOL/-26-0-BETA-D-GLUCOPYRANOSIDE | 0 |
|
SU1162817A1 |
| NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG AND SALT THEREOF AND DIABETES THERAPEUTIC AGENT CONTAINING SAID COMPOUNDS | 2005 |
|
RU2394015C2 |
| DERIVATIVES OF ARYL-5-THIO-β-D-GLYCOPYRANOSIDE AND THERAPEUTIC AGENT COMPRISING THEREOF USED IN DIABETES MELLITUS | 2003 |
|
RU2322449C2 |
